Role of Ghrelin and Insulin-like Growth Factor Binding Protein-3 in the Development of Osteoporosis in Inflammatory Bowel Disease

Journal of Clinical Gastroenterology

Volumn 45, Issue 6, 2011, Pages e60-e65

  Koutroubakis, Ioannis E ^a   Zavos, Christos ^a   Damilakis, John ^b   Papadakis, Georgios ^b   Neratzoulakis, John ^b   Karkavitsas, Nikolaos ^b   Kouroumalis, Elias A ^b  

^a Departments of Gastroenterology   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Adipokines; Bone mineral density; Crohn's disease; Ulcerative colitis

Indexed keywords

GHRELIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; CORRELATION ANALYSIS; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RISK FACTOR; ULCERATIVE COLITIS;

ABSORPTIOMETRY, PHOTON; ADULT; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR NECK; GHRELIN; HUMANS; INFLAMMATORY BOWEL DISEASES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LEPTIN; LUMBAR VERTEBRAE; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 79958852645     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181f42543     Document Type: Article

References (38)

1. Bernstein CN. Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:152-156
2. Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:797-813
3. Tilg H, Moschen AR, Kaser A, et al. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57:684-694
4. Ensrud KE, Lipschutz RC, Cauley JA, et al. Body size and hip fracture risk in older women—A prospective study. Am J Med. 1997;103:274-280
5. Reid IR, Ames RW, Evans MC, et al. Determinants of the rate of bone loss in normal postmenopausal women. J Clin Endocrinol Metab. 1994;79:950-954
6. Reid IR. Relationships between fat and bone. Osteoporos Int. 2008;19:595-606
7. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009;122:409-414
8. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;29:535-559
9. Agnusdei D, Gentilella R. GH and IGF-I as therapeutic agents for osteoporosis. J Endocrinol Invest. 2005;28(suppl):32-36
10. Kveiborg M, Flyvbjerg A, Rattan SI, et al. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol. 2000;35:1061-1074
11. Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:100-105
12. Ates Y, Degertekin B, Erdil A, et al. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci. 2008;53:2215-2221
13. Katsanos KH, Tsatsoulis A, Christodoulou D, et al. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res. 2001;11:364-367
14. Eivindson M, Grønbaek H, Skogstrand K, et al. The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand J Gastroenterol. 2007;42:464-470
15. Stange EF, Travis SPL, Vermeire S, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55:1-15
16. Stange EF, Travis SPL, Vermeire S, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55:1-15
17. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36
18. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444
19. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32
20. Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Miner Res. 2002;17:1563-1569
21. Hebebrand J, Blum WF, Barth N, et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997;2:330-334
22. Legroux-Gérot I, Vignau J, Biver E, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporos Int. 2010 [Epub ahead of print] PMID: 20052458.
23. Toussirot E, Nguyen NU, Dumoulin G, et al. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatol Oxford. 2005;44:120-125
24. Wisłowska M, Rok M, Jaszczyk B, et al. Serum leptin in rheumatoid arthritis. Rheumatol Int. 2007;27:947-954
25. Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, et al. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol. 2009;36:512-516
26. Karmiris K, Koutroubakis IE, Xidakis C, et al. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2007;19:789-794
27. Caminos JE, Gualillo O, Lago F, et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology. 2005;146:1285-1292
28. Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol. 2005;184:249-256
29. Misra M, Prabhakaran R, Miller KK, et al. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab. 2008;93:1292-1297
30. Martini G, Valenti R, Giovani S, et al. Influence of insulinlike growth factor-I and leptin on bone mass in healthy postmenopausal women. Bone. 2001;28:113-117
31. Ravn P, Overgaard K, Spencer EM, et al. Insulin-like growth factors I, and II in healthy women with and without established osteoporosis. Eur J Endocrinol. 1995;132:313-319
32. Seck T, Bretz A, Krempien R, et al. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. Bone. 1999;24:387-393
33. Eivindson M, Grønbaek H, Skogstrand K, et al. The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand J Gastroenterol. 2007;42:464-470
34. Sylvester FA, Wyzga N, Hyams JS, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:42-50
35. Schoon EJ, Blok BM, Geerling BJ, et al. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology. 2000;119:1203-1208
36. Habtezion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis. 2002;8:87-92
37. Leslie WD, Miller N, Rogala L, et al. Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD cohort study. Inflamm Bowel Dis. 2009;15:39-46
38. Lee N, Radford-Smith GL, Forwood M, et al. Body composition and muscle strength as predictors of bone mineral density in Crohn's disease. J Bone Miner Metab. 2009;27:456-463